Novel capsaicin analogues as potential anticancer agents: synthesis, biological evaluation, and in silico approach.

Mariana C F C B Damião, Kerly F M Pasqualoto, Adilson K Ferreira, Sarah F Teixeira, Ricardo A Azevedo, José A M Barbuto, Fanny Palace-Berl, Gilberto C Franchi-Junior, Alexandre E Nowill, Maurício T Tavares, Roberto Parise-Filho

Index: Arch. Pharm. (Weinheim) 347(12) , 885-95, (2014)

Full Text: HTML

Abstract

A novel class of benzo[d][1,3]dioxol-5-ylmethyl alkyl/aryl amide and ester analogues of capsaicin were designed, synthesized, and evaluated for their cytotoxic activity against human and murine cancer cell lines (B16F10, SK-MEL-28, NCI-H1299, NCI-H460, SK-BR-3, and MDA-MB-231) and human lung fibroblasts (MRC-5). Three compounds (5f, 6c, and 6e) selectively inhibited the growth of aggressive cancer cells in the micromolar (µM) range. Furthermore, an exploratory data analysis pointed at the topological and electronic molecular properties as responsible for the discrimination process regarding the set of investigated compounds. The findings suggest that the applied designing strategy, besides providing more potent analogues, indicates the aryl amides and esters as well as the alkyl esters as interesting scaffolds to design and develop novel anticancer agents. © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.